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Abstract 
Background: Facial scarring can have a dramatic effect on a patient’s psychological health 
and wellbeing and present unique management challenges. This patient population remains 
poorly characterised in the contemporary literature. 
Aims: To evaluate the prevalence of, and risk factors associated with affective disorders in 
adult patients with facial scars.  
Methods: A systematic review was conducted using a protocol registered with PROSPERO 
and in line with the PRISMA statement. A comprehensive search of the literature was 
conducted using PubMed, MEDLINE, EMBASE, PSYCHInfo and The Cochrane Library.  
Results: Twenty one studies were included, with a total of 2,394 participants. Using a random 
effects model, the weighted pooled prevalence of anxiety was 26.1% (95% CI 17.9%-36.3%) 
and the weighted pooled prevalence of depression was 21.4% (95% CI 15.4%-29.0%). 
Studies identified female gender, past psychiatric history and violent causation as factors 
associated with anxiety and depression.   
Limitations: Included studies were limited to those published in peer reviewed journals. 
Longitudinal trends in both anxiety and depression were limited by a short duration of follow 
up. 
Conclusions: There is a high and persistent burden of affective disorders in patients with 
facial scars. Additional research is required to further characterise this population and 
develop effective management strategies.  
 
 
 
 
 
 
 
 
 
Introduction 
It is estimated that 569,000 people are living with a facial disfigurement in the United 
Kingdom(Changing Faces, 2017). Aetiology for facial scarring is diverse and can be present 
at birth or acquired throughout life across all patient demographics(Bayat et al., 2003). In 
addition to physical symptoms, facial scarring can have significant psychosocial implications 
on a patient’s health and well-being(Rumsey and Harcourt, 2004). Despite an improved 
understanding of scar pathophysiology and advances in surgical technique, effective 
treatment of facial disfigurement remains limited(De Sousa, 2008). It is, therefore, essential 
that the psychosocial needs of these patients are adequately assessed and addressed(Roberts 
and Gierasch, 2013). 
 
The face is essential for social interaction and is thought to be the most important physical 
feature in formulating our perception of identity(Shaw, 1981). In a society which is pre-
occupied with appearance and the pursuit of a “perfect” body image, the consequences of 
facial scarring can be far reaching.  
 
Price (1990) developed one of the most recognised models of body image; consisting of three 
main components: body reality (the way our body actually is), body ideal (our perception of 
how our body should look, feel and behave) and body presentation (how our body appears to 
others). These components are influenced by individual coping strategies and social support 
networks(Price, 1990). The association of facial scarring and an altered body image is well 
documented in the literature(Macgregor, 1982, 1990; Rumsey and Harcourt, 2004). Facial 
scarring often leads to a pre-occupation with appearance, lower self confidence and negative 
perceptions from others; leading to an altered body image(Rumsey et al., 1986; Rumsey and 
Harcourt, 2004). This, in turn, creates a vulnerability to developing mental health conditions 
(Rumsey and Harcourt, 2004). As demonstrated in numerous studies, facial scarring reduces 
health-related quality of life(Levine et al., 2005; Stubbs et al., 2011). However, there are few 
studies investigating the association between facial scarring and anxiety or depression. 
 
Anxiety is defined by pathological worry or dread, that undermines normal function, 
whereas depression is characterised by low mood and anhedonia(American Psychiatric 
Association, 2013). Left untreated, both diseases are common causes of disability with a 
broad impact on morbidity and mortality which are well documented in the 
literature(Fawcett, 1993). Symptoms of depression and anxiety are linked with increased 
health costs, influence patient compliance with health care, substance misuse, 
unemployment and poor results in education(McLaughlin, 2011). This aspect of facial 
scarring is often overlooked by services that are primarily concerned with physical health, 
leading to sub-optimal care(Bisson et al., 1997). This occurs despite numerous authoritative 
publications prioritise psychological rehabilitation as one of their key recommendations 
following facial burns or trauma(Choudhury-Peters and Dain, 2016; National Network for 
Burn Care, 2013). 
 
To our knowledge, the prevalence of anxiety and depression in patients with facial has not 
been systemically assessed. Therefore, a systematic review and meta-analysis was performed 
to assess the relationship between facial scarring and anxiety and/or depression. Given the 
extensive research into the psychosocial repurcussions of facial scarring, as outlined above, 
we hypothesised that the prevelance of anxiety and depression would be higher in this 
population group.  
 
Methods: 
Search Strategy and Selection Criteria 
A systematic review protocol was developed in accordance with the Preferred Reporting for 
Items for Systematic Reviews and Meta-Analyses-Protocols (PRISMA-P) and registered with 
PROSPERO (CRD42017075415). The search strategy was constructed in line with PRISMA 
guidelines(Moher et al., 2009), the Cochrane handbook(Higgins JPT, 2011), and guidance 
from Terwee et al(Terwee et al., 2012). To identify all papers that investigated the association 
of facial scarring and anxiety and/or depression, three separate constructs were explored; 
Facial scarring, depression and anxiety. Searches were performed in MEDLINE (Ovid), 
Embase (Ovid), PyschINFO (Ovid), Cochrane and CINAHL (EBSCO). An example search 
strategy can be seen in Supplementary Figure 1. Grey literature and reference lists were also 
searched using Google and Google Scholar. Searches were performed by two independent 
researchers on the same day in September 2017, with results uploaded to the reference 
management software package, EndNote® Version X7 (Clarivate Analytics). Duplicates 
were removed using the functionality in EndNote®, with all references transferred to the 
online programme Covidence (www.covidence.org) for title and abstract screening. 
References were screened by two independent reviewers (EA and JG) according to the 
inclusion and exclusion criteria (Table 1), with all remaining articles downloaded in full-text 
format and re-screened. Discrepancies were discussed between the two reviewers with a third 
reviewer (TD) consulted if required. 
Table 1. Inclusion and exclusion criteria for choosing studies.  
Inclusion Criteria  Exclusion Criteria  
• Any paper describing a study 
looking at facial scarring and 
depression or anxiety. 
• Any cause for facial scarring.  
• Any scoring system for depression 
or anxiety. 
• English language studies only. 
• Non-English language papers. 
• Studies not investigating an 
association between facial scarring 
and anxiety or depression. 
 
Data extraction and analysis  
Data was extracted from all papers included in the final review by two reviewers (EA and 
JG). Data pertaining to study and participant characteristics, symptoms of anxiety and/or 
depression and method of measurement were extracted. All data were then uploaded to Excel 
(2016, Microsoft Corp., Redmond, USA) for analysis. 
 
Assessment of Bias 
Individual studies were assessed for risk of bias using the validated Quality in Prognosis 
Studies (QUIPs) tool (Hayden et al., 2013). Studies were assessed for bias in one of five 
domains; study participation, study attrition, outcome measurement, study confounding and 
statistical analysis and reporting. Each of the five domains was rated as having a high, 
moderate or low risk of bias. A summated score of the five domains was then calculated. 
Publication bias was assessed with funnel plots and Eggers test(Sterne and Egger, 2001).  
 
Statistical Analysis 
Between study heterogeneity was calculated using the I2 statistic, a description of the 
percentage of total variation across studies caused by heterogeneity. A value of 0% represents 
minimal heterogeneity and higher values represent greater heterogeneity. Pooled data that 
was classified as having low heterogeneity ( I2 <50%) were analysed using a fixed effects 
model, which assumes that studies are conducted under similar conditions (e.g same sample 
size, similar subjects). Pooled data that was classified as having moderate to high 
heterogeneity ( I2 >50%) were analysed using a random effects model, which adjusts for 
within and between study variability(Borenstein et al., 2010; Higgins et al., 2003). 
 
Pooled prevalence was calculated based on dichotomous event rates and weighted based on 
sample size with a 95% CI. For longitudinal studies measuring prevalence at multiple time 
points, the prevalence at the final assessment was used for the pooled prevelance. Forest plots 
were generated to graphically display the results of the pooled analysis using DistillerSR 
Forest Plot Generator from Evidence Partners (Ottawa, Ontario, Canada). All statistical 
analysis was performed using the Comprehensive Meta-Analysis software package (Biostat, 
Englewood, New Jersey, USA).  
 
Results  
A total of 964 studies were identified using our search strategy, which after review left 21 
articles conducted between 1996 and 2016, in our analysis (Table 2)(Bisson et al., 1997; 
Choudhury-Peters and Dain, 2016; Fares et al., 2014; Gandjalikhan-Nassab et al., 2016; 
Gironda et al., 2009; Hoogewerf et al., 2014; Hull et al., 2003; Islam et al., 2012a; Lento et 
al., 2004; Levine et al., 2005; Murphy et al., 2010; Prashanth et al., 2015; Rahtz et al., 2018; 
Robinson et al., 1996; Sen et al., 2001; Shetty et al., 2003; Shiraz et al., 2014; Tebble et al., 
2006; Ukpong et al., 2007; Ukpong et al., 2008). Fifteen studies examined the prevalence of 
depression (Bisson et al., 1997; Choudhury-Peters and Dain, 2016; Fares et al., 2014; 
Gandjalikhan-Nassab et al., 2016; Gironda et al., 2009; Hoogewerf et al., 2014; Hull et al., 
2003; Islam et al., 2012a; Rahtz et al., 2018; Sen et al., 2001; Shepherd et al., 1990; Shetty et 
al., 2003; Shiraz et al., 2014; Ukpong et al., 2008; Versnel et al., 2012) and 13 articles 
examined the prevalence of anxiety (Bisson et al., 1997; Choudhury-Peters and Dain, 2016; 
Fares et al., 2014; Gandjalikhan-Nassab et al., 2016; Hull et al., 2003; Islam et al., 2012a; 
Rahtz et al., 2018; Sen et al., 2001; Shepherd et al., 1990; Shetty et al., 2003; Shiraz et al., 
2014; Ukpong et al., 2008; Versnel et al., 2012); 13 articles looked at the prevalence of both 
anxiety and depression (Bisson et al., 1997; Choudhury-Peters and Dain, 2016; Fares et al., 
2014; Gandjalikhan-Nassab et al., 2016; Hull et al., 2003; Islam et al., 2012a; Rahtz et al., 
2018; Sen et al., 2001; Shepherd et al., 1990; Shetty et al., 2003; Shiraz et al., 2014; Ukpong 
et al., 2008; Versnel et al., 2012). Nine articles looked at mean depression scores and 7 
articles looked at mean anxiety scores; 8 articles looked at both mean depression and mean 
anxiety scores. Studies were most commonly of cohort design (40%) and all studies were 
carried out in an outpatient environment. Nine of the studies (43%) were cross-sectional, 
without a second time-point, and 13 (57%) were longitudinal.  
 
 
 
 
 
Figure 1 Prisma Flow Diagram.  
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 Table 2: Summary of studies included and their characteristics 
First Author Year Country  Study Design Setting 
Initial 
Sample 
Size 
Time Since 
Scar-Event  
Male 
(%) 
Mean 
Age 
Violent 
Cause Depression Anxiety 
Bisson(Bisson et al., 1997) 1997 UK Prospective Case Series OPD 43 
On 
Admission, 
7 weeks 
85 31 27 HADS HADS 
Choudhury-Peters 
(Choudhury-Peters and 
Dain, 2016) 
2016 UK Prospective Case Series OPD 150 
1-3 months, 
6-9 months 73 NS NS 
Bespoke 
Questionnaire 
Bespoke 
Questionnaire 
Fares (Fares et al., 
2014) 2014 Lebanon 
Retrospective 
Case Series 
Patient 
Records 29 
Not 
specified. 76 
27 
(median) 100 DSM-IV DSM-IV 
Gandjalikhan-
Nassab(Gandjalikhan-
Nassab et al., 2016) 
2016 Iran  Prospective Case-Control IPD 50 
Not 
specified. 60 21.3 NS HADS HADS 
Gironda (Gironda et al., 
2009) 2009 USA Cohort IPD, OPD  84 
On 
admission, 1 
month, 2 
months, 3 
months 
87 35 NS CES-D  NI 
Hoogewerf(Hoogewerf 
et al., 2014)  2014 Netherlands  
Prospective 
Case Series OPD 132 
3 weeks, 3 
months, 6 
months 
83 40.2 NS HADS HADS 
Hull  (Hull et al., 2003) 2003 UK Prospective Case Series IPD, OPD 39 
<10 days, 4-
6 weeks 85 31 74 HADS HADS 
Islam  (Islam et al., 
2012a) 2012 
UK + 
Australia 
Prospective 
Case-Control OPD 102 
Cross-
Sectional @ 
3.5 weeks 
(mean) 
77 33 NS HADS HADS 
Lento (Lento et al., 
2004) 2004 USA Cohort IPD, OPD 203 
10 days, 6 
months, 12 
months 
75 32 NS BSI  BSI  
Levine (Levine et al., 
2005) 2005 USA 
Retrospective 
Case Series 
Patient 
Records 20 
Cross-
sectional @ 
1 year 7 
months 
(mean) 
65 28 NS CES-D  NI 
  
 
 
Murphy(Murphy et al., 
2010) 2010 USA 
Retrospective 
Case-Control OPD 71 
Cross-
Sectional @ 
<1 year 
86 18 41 BSI  BSI  
Prashanth (Prashanth et 
al., 2015) 2016 India  Cohort IPD, OPD 153 
Discharge, 1 
month PO, 6 
months PO 
53 ? NS HADS HADS 
Rahtz(Rahtz et al., 
2018) 2018 UK Cohort IPD, OPD 107 
21 days, 8 
months 75 ? NS HADS HADS 
Robinson (Robinson et 
al., 1996) 1996 UK Cohort 
Charity 
Workshop  64 
Cross-
Sectional @ 
16.1 years 
36 32.9 NS HADS HADS 
Sen (Sen et al., 2001) 2001 UK Prospective Case-Series IPD, OPD 46 
Pre-op, 12 
months 91 34 NS HADS HADS 
Shepherd(Shepherd et 
al., 1990) 1990 UK 
Prospective 
Case-Series OPD 70 
1 week, 3 
months 75 26 100 HADS, BSI HADS, BSI 
Shetty (Shetty et al., 
2003) 2014 USA 
Prospective 
Case Series IPD, OPD 336 
<10 days, 1 
month, 6 
months, 12 
months 
89 71% <40 83 BSI  BSI  
Shiraz (Shiraz et al., 
2014) 2014 UK 
Prospective 
Case-Control OPD 96 
Not 
specified. 87 34 NS HADS HADS 
Tebble (Tebble et al., 
2006) 2006 UK 
Prospective 
Case-Series OPD 63 
1 week, 6 
months 81 30 NS NI STAI 
Ukpong (Ukpong et al., 
2008) 2008 Nigeria  
Prospective 
Case-Series IPD, OPD 126 
<1 week, 6-
8 weeks, 10-
12 weeks 
89 34 6 HADS HADS 
Versnel (Versnel et al., 
2012) 2012 Netherlands 
Retrospective 
Case-Series 
Patient 
Records 59 
Cross-
Sectional @ 
7-years 
41 43 Excluded  HADS HADS 
 
OPD-Outpatient   IPD-Inpatient  NS – Not Specified  HADS-Hospital Anxiety and Depression Score  BSI- Brief Symptom Inventory  CES-D – Center for Epidemiologic Studies Depression Scale 
DSM-IV – Diagnostic Statistical Manual of Mental Disorders 4th ed  NI- Not Included  STAI- State Trait Anxiety Inventory 
 
 A total of 2043 patients were included in the 21 studies, 76% were male. Of the 18 studies 
that provided mean age data (n=1622), the mean age was 33 years. Eight studies (40%) 
looked at patients whose facial scars had a violent aetiology, two studies (10%) exclusively 
focused on this.  
 
Fourteen studies (67%) used the Hospital Anxiety and Depression Scale to assess depression 
and anxiety. A non-objective measures of depression and anxiety was used in one study [23] 
and one study used a non-validated questionnaire [15]. 
 
Prevalence 
Between study heterogeneity was high in both studies that focused on anxiety (I2=89.154) 
and depression (I2=86.093).The weighted pooled prevalence, calculated using the random 
effects model is displayed in Table 3. Forest plots for the outcomes are displayed in Figure 2 
(Anxiety) and Figure 3 (Depression). Sub group data were not presented in the majority of 
studies, thus subgroup analyses were not performed. 
The highest prevalence of anxiety and depression was observed by Fares (Fares et al., 2014). 
In a small population of trauma victims 79.3% met the diagnostic criteria for anxiety and 
72.4% met the criteria for depression. The lowest prevalence of anxiety and depression was 
reported by Versnel (Versnel et al., 2012) in a population with congenital facial deformities. 
Prevalence of anxiety was 11% and depression 5%.  
Table 3 – Weighted pooled prevalence of anxiety and depression in patients following 
facial scarring using a random effects model. 
 
 
  Studies Included N Prevalence, % 95% CI 
Anxiety 13 1113 26.1 17.9-36.3 
Depression 15 1302 21.4 15.4-29.0 
 Figure 2 Forest Plot and pooled and pooled analysis of Anxiety Prevalence in Patients 
with facial scarring.  
 
 
PREV –Prevalence LCL- Lower Confidence Limit UCL – Upper Confidence Level 
WGHT-Weight 
 
 Figure 3 Forest Plot and pooled and pooled analysis of Depression Prevalence in 
Patients with facial scarring. 
 
PREV –Prevalence LCL- Lower Confidence Limit UCL – Upper Confidence Level 
WGHT-Weight 
 
 
 
 Longitudinal Trends in Prevelance 
The prevalence of anxiety decreased in six studies and remained static in two. The mean 
anxiety score decreased in all of the four studies that calculated mean anxiety scores at more 
than one time point. Depression followed a similar trend; prevalence decreased in eight 
studies and remained level in one. Of the studies that calculated mean scores over time, 
depression scores also decreased. The maximum follow up time was one year (Sen et al., 
2001) whilst the minimum was seven weeks(Bisson et al., 1997). Pooled prevalence is 
displayed in Table 4 and Table 5. 
 
Table 4- Pooled Prevalence of Anxiety Using a Random Effects Model 
 
Studies 
Included N 
Prevalence, 
% 95% CI 
Time point 1 (7 days to 3 months post 
scarring) 8 
73
4 24.4 
13.4-
40.0 
Time point 2 (7 weeks to 1 year post scarring) 8 
45
2 21.8 
12.6-
34.9 
 
 
Table 5- Pooled Prevalence of Depression Using a Random Effects Model 
 
Studies 
Included N 
Prevalence, 
% 95% CI 
Timepoint 1 (7 days to 3 months post 
scarring) 9 
84
9 23.6 
16.1-
33.3 
Timepoint 2 (7 weeks to 1 year post scarring) 9 
54
7 16.1 9.8-23.3 
 
 
Associated Factors 
Of the 21 papers included in the review, eight considered factors associated with depression 
and anxiety. Being a victim of assault increased the prevalence of both anxiety and 
depression in a number of studies, compared to those that sustained a scar from an accident 
 (Bisson et al., 1997; Islam et al., 2012a; Murphy et al., 2010; Shepherd et al., 1990; Tebble et 
al., 2006). Conflicting evidence is present concerning scar severity; Tebble et al(Tebble et al., 
2006) concluded that the size of scar was associated with increased depression and anxiety in 
patients with lacerations, however this observation was not noted in a population of patients 
with facial burns(Hoogewerf et al., 2014) where scar severity was not associated with 
depression or anxiety. The discrepancy could be explained by the differences in the 
mechanism of facial injury, the method of classifying scar severity or the degree of 
psychological trumatisation associated with different events. Tebble et al(Tebble et al., 2006) 
gained objective evidence by measuring scar length whereas patient rated scar severity was 
assessed by Hoogewerf(Hoogewerf et al., 2014).  
 
Female patients were found to have an increased risk of anxiety(Gandjalikhan-Nassab et al., 
2016; Islam et al., 2012b; Tebble et al., 2006) however this trend was not observed with 
depression(Hoogewerf et al., 2014; Shiraz et al., 2014). History of previous psychiatric 
disorder(Bisson et al., 1997) was associated with increased risk of depression whilst age and 
social support had no relationship with either depression or anxiety(Hoogewerf et al., 2014; 
Shiraz et al., 2014; Tebble et al., 2006). 
 
Bias 
Significant bias was noted amongst the studies; 17 studies were classified as having moderate 
or high risk of bias (Table 6). Frequently the study data did not reflect the study sample; 
patients lost to follow up were frequently not accounted for and reasons for study withdrawal 
were not often explored. Whilst the majority of studies incorporated a validated screening 
tool for anxiety and depression, the reporting of results was not entirely consistent. Several 
studies simply reported the mean score for the study population, omitting the proportion of 
 patients that had scores consistent with a diagnosis of anxiety or depression. This limits the 
clinical relevance of these studies. Asymmetry is noted in the funnel plots, however Eggers 
test was not significant for either anxiety (p= 0.13) or depression (p=0.31) indicating that 
publication bias was not present. Asymmetry of the funnel plots could be explained by the 
degree of heterogeneity between studies (Sterne and Egger, 2001). 
 
Table 6- Assessment of bias 
First Author Year 
Study 
Participation 
Study 
attrition 
Outcome 
Measure 
Study 
Confounding 
Statistical 
Analysis and 
Reporting  Overall 
Bisson[12] 1997 High High Low Low Low Moderate 
Choudhury-
Peters [15] 
2016 
High High Moderate Low Low Moderate 
Fares [23] 2014 High N/A Moderate High Moderate High 
Gandjalikhan-
Nassab[24] 
2016 
High N/A Moderate Low Low Moderate 
Gironda [25] 2009 Moderate Low Moderate Low Low Low 
Hoogewerf[26]  2014 
Low High Low Low Low Low 
Hull  [27] 2003 Low High Low Low Low Moderate 
Islam  [28] 2012 Low Low Low High Low Low 
Lento [29] 2004 Low High High Moderate High Moderate 
Levine [13] 2005 High High High Low High High 
Murphy[30] 2010 Low High High High High High 
Prashanth 
(Prashanth et 
al., 2015) 
2016 
Low Low Low Low High Moderate 
Rahtz (Rahtz et 
al., 2018) 
2018 
Low moderate Low Low low Low 
Robinson [32] 1996 Moderate Low Moderate Low Low Moderate 
Sen [33] 2001 High High Low High Low Moderate 
Shepherd 
(Shepherd et 
al., 1990) 
1990 
High High Low High High High 
Shetty (Shetty 
et al., 2003) 
2014 
High High Low High High High 
Shiraz (Shiraz 
et al., 2014) 
2014 
Moderate Moderate Moderate Low Low Moderate 
Tebble (Tebble 
et al., 2006) 
2006 
Moderate Moderate High Low High Moderate 
Ukpong 
(Ukpong et al., 
2008) 
2008 
Moderate Moderate Low High Low Moderate 
Versnel 
(Versnel et al., 
2012) 
2012 
Low Moderate Moderate Low High Moderate 
 
  
Figure 4 Funnel Plot of Prevalence of Anxiety 
 
Figure 5 – Funnel Plot of Prevalence of Depression 
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 Discussion  
This systematic review identified 21 studies examining the association of affective disorders 
and facial scarring. The prevalence of anxiety was 26% in patients with facial scarring whilst  
the prevalence of depression was 21%. The prevalence of anxiety and depression appear to 
decrease with time. The paucity of longitudinal data over one year, however, impedes our 
ability to fully characterise the trend in prevalence over time.  Female gender, violent 
aetiology and premorbid psychopathology were identified as risk factors for anxiety and 
depression. 
 
This review demonstrates that there is a significant burden of both anxiety and depression in 
patients with facial scarring, with both conditions being over-represented when compared to 
the general population, where the prevalence of anxiety disorders is 10.6% (Remes et al., 
2016) and that of depressive symptoms 11.4%(Crawford et al., 2001). Explanations for these 
results are numerous. Rumsey and Harcourt (Rumsey and Harcourt, 2004) argue that the 
difficulties most commonly expressed by those with disfiguring conditions relate to a 
negative body image and difficulties with social interaction. In a study of young adults with 
cleft palates, 73% of participants reported low self confidence and unfavourable body 
image(Turner et al., 1997). These problems in turn lead to maladaptive thought processes (e.g 
fear of negative social evaluation) and negative behavioural patterns such as social 
avoidance. Social interactions are affected by visible differences in many ways. Making new 
friends can be difficult and reports of bullying are common(Turner et al., 1997). This is 
further compounded by the fact that many facial disfigurements may interfere with body 
language(Macgregor, 1990). These explanations are clearly simplistic and the weight of 
evidence suggests that the association is multifactorial. 
 
 The prevalence of mental illness is modulated by multiple factors. Several papers in this 
review demonstrated female gender to be associated with higher rates of psychopathology 
[18, 23, 24], a finding that is in keeping with general population studies (Bottomley et al., 
2010; Merikangas et al., 2011). Other work has shown that females score higher on measures 
of maladaptation to disfigurement than males (Rahtz et al., 2018). Therefore, it may be that 
there is a composite relationship of female gender and facial scarring in the risk for 
developing psychopathology. Prevalence is also increased in patients who have scar(s) 
caused by violent methods[10, 18-21]; this is true of trauma patients in general(Rahtz et al., 
2017). Finally, pre-morbid psychiatric illness was also shown to be associated with 
psychopathology[10] but this, unlike gender, was not controlled for in many of the case-
control studies. This limits conclusions that can be drawn about the importance of previous 
anxiety or depressive episodes on the impact of facial scarring but it seems likely they are 
important given work in other populations (Bottomley et al., 2010). 
 
Given methodological differences, it is difficult to directly compare our findings with other 
studies but the prevalence of anxiety and depression found in this study is slightly less than 
those reported for facial palsy(Fu et al., 2011) and facial paralysis(Pouwels et al., 2016). The 
findings suggest that facial scarring may result in a similar burden of depression but lower 
burden of anxiety than seen in acne patients(Lukaviciute et al., 2017), and a lower burden of 
depression compared to orthopaedic trauma patients(Muscatelli et al., 2016). When compared 
to patients with chronic medical disorders, however, there is a higher prevalence of 
depression with facial scarring patients compared to Diabetes Mellitus (9.3%), Chronic 
Obstructive Pulmonary Disease (COPD) (15.4%) and End-Stage Renal Disease (ESRD) 
(17.0%)(Egede, 2007). Patients with the latter conditions routinely receive more regular 
contact from health care providers and, therefore, there is greater opportunity to identify 
 developing psychological comorbidity. Whether this, the actual disfigurement or other factors 
underly the disparity in prevalence is unclear and either way there is an evident shortfall in 
psychological care for patients with facial scars.  
 
Limitations 
This systematic review and meta-analysis combined data across studies in order to estimate 
the prevalence of depression and anxiety in patients with facial scarring. The main limitation 
of this study, as with most reviews, is that patient populations, outcome measures and clinical 
settings are not homogenous across studies. Notably, there was great variation in the metrics 
used, timing of diagnostic screening and thresholds used to define depression and anxiety. 
Furthermore, the data presented in the studies limits our ability to comment on the severity of 
the depression or anxiety. The lack of longitudinal data bias the findings towards the initial 
phase of recovery and makes comparison of prevalence at different time points difficult. 
Whilst confounding factors were established in a few studies, there remains a paucity of 
information on risk factors for depression and anxiety in this group of patients. Finally, the 
design of the included studies was able to demonstrate associations but did not allow the 
inference of causality to be made.  
 
Conclusions 
Overall, there is a considerable burden of anxiety and depression in patients with facial scars. 
From a clinical perspective, our study has demonstrated the requirement for formal mental 
state assessment in trauma clinics; this being infrequently perfomed at present. Early 
detection and treatment are likely to improve the health and wellbeing of patients with facial 
scars who suffer from anxiety and depression.  Factors such as gender, past psychiatric 
history and violent circumstances of facial injury are all associated with increased prevalence 
 and dissemination of this knowledge will help healthcare providers detect, treat and offer 
additional support to this select patient group. 
 
The optimal strategy to holistically detect and treat anxiety and depression in facial scarring 
remains unkown. Future studies should aim to determine the efficacy of existing treatment 
options and consider the need for development of more bespoke approaches for this select 
patient group. Further work is also required to determine the longitudinal relationship of 
anxiety and depression in patients with facial scarring.  
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Supplementary Figure 1 
Search strategy 
#1 Facial Injury*.mp  
#2 Facial Injuries MeSH term explode all trees 
#3 Facial Trauma .mp 
#4 Facial Scar* 
#5 Facial Scarring 
#6 Anxiety Disorder MeSH term explode all trees 
#7 Anxiety .mp 
#8 Depression .mp 
#9 Depression MeSH term explode all trees 
#10 #1 OR #2 OR #3 OR #4 OR#5 
#11 #6 OR #7 OR #8 OR #9 
#12 #10 AND#11 
 
(facial injuries.mp. OR exp facial injuries/ OR facial trauma.mp. OR facial burn.mp. OR 
facial scar.mp OR facial scarring.mp.) AND (exp anxiety disorders/ OR anxiety.mp. OR exp 
anxiety/ OR depression.mp. OR exp depression/) 
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